Clinical Trial Update: Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate the safety of Fazirsiran and its potential to help people with Alpha-1 Antitrypsin Deficiency–related liver d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• Fazirsiran (fazirsiran)

Snippet

Sponsor: Takeda | Conditions: Alpha1-Antitrypsin Deficiency | Phase 3 | Status: RECRUITING